4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001489966-26-000004
Options or other derivatives
- Chief Medical Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Morris Charles Q Chief Medical Officer | 2026-05-01 | Grant or award · Employee Stock Option (right to buy) | +450,000 | $4.70 | $2,115,000 | 450,000 | D |
Loading xslF345X06/primarydocument.xml…